PROCARDIA Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Procardia, and what generic alternatives are available?

Procardia is a drug marketed by Pfizer and is included in two NDAs.

The generic ingredient in PROCARDIA is nifedipine. There are thirty-nine drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the nifedipine profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Procardia

A generic version of PROCARDIA was approved as nifedipine by ACTAVIS ELIZABETH on September 20^th, 1990.

Try a Trial

Summary for PROCARDIA

US Patents:	0
Applicants:	1
NDAs:	2
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	165
Clinical Trials:	11
Patent Applications:	3,750
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for PROCARDIA
What excipients (inactive ingredients) are in PROCARDIA?	PROCARDIA excipients list
DailyMed Link:	PROCARDIA at DailyMed

Drug patent expirations by year for PROCARDIA

Recent Clinical Trials for PROCARDIA

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Medical College of Wisconsin	N/A
Icahn School of Medicine at Mount Sinai	Phase 4
University of Tennessee Medical Center	Early Phase 1

See all PROCARDIA clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for PROCARDIA

C08CA	Dihydropyridine derivatives
C08C	SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS
C08	CALCIUM CHANNEL BLOCKERS
C	Cardiovascular system

US Patents and Regulatory Information for PROCARDIA

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pfizer	PROCARDIA	nifedipine	CAPSULE;ORAL	018482-001	Approved Prior to Jan 1, 1982	AB	RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Pfizer	PROCARDIA XL	nifedipine	TABLET, EXTENDED RELEASE;ORAL	019684-002	Sep 6, 1989	AB2	RX	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Pfizer	PROCARDIA	nifedipine	CAPSULE;ORAL	018482-002	Jul 24, 1986		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for PROCARDIA

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pfizer	PROCARDIA	nifedipine	CAPSULE;ORAL	018482-002	Jul 24, 1986	⤷ Try a Trial	⤷ Try a Trial
Pfizer	PROCARDIA	nifedipine	CAPSULE;ORAL	018482-002	Jul 24, 1986	⤷ Try a Trial	⤷ Try a Trial
Pfizer	PROCARDIA	nifedipine	CAPSULE;ORAL	018482-001	Approved Prior to Jan 1, 1982	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for PROCARDIA

See the table below for patents covering PROCARDIA around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Netherlands	154935		⤷ Try a Trial
Japan	S58121210	MANUFACTURE OF INSTANTANEOUS MOUTH DISCHARGING SUBLINGUAL SOFT CAPSULE MEDICINE	⤷ Try a Trial
Japan	S6119604		⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Summary for PROCARDIA

Recent Clinical Trials for PROCARDIA

Anatomical Therapeutic Chemical (ATC) Classes for PROCARDIA

Make Better Decisions: Try a trial or see plans & pricing